Kahatt, C : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (44)
Les plus populaires
Liste
- Liste
- Tableau

1

PREVI-Lima’s Time: Positioning Proyecto Experimental de Vivienda in Peru’s Modern Project

Sharif S Kahatt

Journal:

Architectural Design

Année:

2011

Langue:

english

Fichier:

PDF, 334 KB

english, 2011

2

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Spicka, Ivan, Ocio, Enrique M., Oakervee, Heather E., Greil, Richard, Banh, Raymond H., Huang, Shang-Yi, D’Rozario, James M., Dimopoulos, Meletios A., Martínez, Sara, Extremera, Sonia, Kahatt, Carmen,

Journal:

Annals of Hematology

Année:

2019

Langue:

english

Fichier:

PDF, 901 KB

english, 2019

3

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis

Claudia Lebedinsky, Javier Gómez, Youn C. Park, Antonio Nieto, Arturo Soto-Matos, Trilok Parekh, Vicente Alfaro, Elena Roy, Pilar Lardelli, Carmen Kahatt

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2011

Langue:

english

Fichier:

PDF, 1.75 MB

english, 2011

4

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

Werner Hilgers, Sandrine Faivre, Stéphanie Chieze, Jérôme Alexandre, François Lokiec, François Goldwasser, Eric Raymond, Carmen Kahatt, Abdelkrim Taamma, Garry Weems, John R. MacDonald, Jean-Louis Mis

Journal:

Investigational New Drugs

Année:

2006

Langue:

english

Fichier:

PDF, 266 KB

english, 2006

5

A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2

Jérôme Alexandre, Carmen Kahatt, Frédérique Bertheault-Cvitkovic, Sandrine Faivre, Stephen Shibata, Werner Hilgers, François Goldwasser, François Lokiec, Eric Raymond, Garry Weems, Ajit Shah, John R.

Journal:

Investigational New Drugs

Année:

2007

Langue:

english

Fichier:

PDF, 188 KB

english, 2007

6

A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin

Grosso, Federica, D’Incalci, Maurizio, Cartoafa, Mirela, Nieto, Antonio, Fernández-Teruel, Carlos, Alfaro, Vicente, Lardelli, Pilar, Roy, Elena, Gómez, Javier, Kahatt, Carmen, Soto-Matos, Arturo, Juds

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 289 KB

english, 2012

7

A Phase II Study of Neoadjuvant Gemcitabine Plus Doxorubicin in Stage IIIB Breast Cancer: A Preliminary Report

Henry Gomez, Carmen Kahatt, Silvia Falcon, Sergio Santillana, Fernando Hurtado de Mendoza, Segundo Valdivia, Carlos Vallejos, Jorge Otero, Daniel Lee Kay Pen

Journal:

Seminars in Oncology

Année:

2001

Langue:

english

Fichier:

PDF, 637 KB

english, 2001

8

Phase I study of MGI 114 (irofulven) exploring 3 different iv schedules (SCH) as a 5 minute infusion in advanced solid tumors (AST): final results

J. Alexandre, S. Chieze, E. Raymond, E. Brain, M. Ould Kaci, S. Smith, S. Lagree, K. Vanderbilt, E. Cvitkovic, C. Kahatt

Journal:

European Journal of Cancer

Année:

2001

Langue:

english

Fichier:

PDF, 182 KB

english, 2001

9

299 POSTER Randomized phase II trial of irofulven/prednisone, irofulven/capecitabine/prednisone, or mitoxantrone/prednisone in hormone refractory prostate cancer (HRPC) patients failing first-line docetaxel: preliminary results

L. Hart, J. Hainsworth, T. Ciuleanu, S. Oudard, E. Berger, J. Alexandre, K. Chi, D. Ruether, C. Kahatt, J. MacDonald

Journal:

European Journal of Cancer Supplements

Année:

2006

Langue:

english

Fichier:

PDF, 59 KB

english, 2006

10

432 Phase Ib study of plitidepsin with bevacizumab in refractory solid tumor patients (pts)

C. Gomez-Roca, T. Besse-Hammer, S. Szyldergemajn, R. Bahleda, M. Diaz, A. Vandermeeren, S. Extremera, C. Kahatt, J.C. Soria, A. Awada

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 47 KB

english, 2010

11

Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies

Goldwasser, Francois, Faivre, Sandrine, Alexandre, Jerome, Coronado, Cinthya, Fernández-García, Eva M., Kahatt, Carmen M., Paramio, Pilar García, Dios, Jorge Luis Iglesias, Miguel-Lillo, Bernardo, Ray

Journal:

Investigational New Drugs

Année:

2014

Langue:

english

Fichier:

PDF, 267 KB

english, 2014

12

Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

Massard, Christophe, Margetts, Jane, Amellal, Nadia, Drew, Yvette, Bahleda, Ratislav, Stevens, Peter, Armand, Jean Pierre, Calvert, Hilary, Soria, Jean Charles, Coronado, Cinthya, Kahatt, Carmen, Alfa

Journal:

Investigational New Drugs

Année:

2013

Langue:

english

Fichier:

PDF, 171 KB

english, 2013

13

Erratum to: Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

Massard, Christophe, Margetts, Jane, Amellal, Nadia, Drew, Yvette, Bahleda, Ratislav, Stephens, Peter, Armand, Jean Pierre, Calvert, Hilary, Soria, Jean Charles, Coronado, Cinthya, Kahatt, Carmen, Alf

Journal:

Investigational New Drugs

Année:

2013

Langue:

english

Fichier:

PDF, 49 KB

english, 2013

14

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors

Sessa, Cristiana, Conte, Gianluca, Christinat, Alexandre, Cresta, Sara, Perotti, Antonella, Gallerani, Elisa, Lardelli, Pilar, Kahatt, Carmen, Alfaro, Vicente, Iglesias, Jorge L., Fernández-Teruel, Ca

Journal:

Investigational New Drugs

Année:

2013

Langue:

english

Fichier:

PDF, 202 KB

english, 2013

15

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

Elez, M. E., Tabernero, J., Geary, D., Macarulla, T., Kang, S. P., Kahatt, C., Pita, A. S.-M., Teruel, C. F., Siguero, M., Cullell-Young, M., Szyldergemajn, S., Ratain, M. J.

Journal:

Clinical Cancer Research

Année:

2014

Langue:

english

Fichier:

PDF, 1.74 MB

english, 2014

16

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study

Delaloge, S., Wolp-Diniz, R., Byrski, T., Blum, J. L., Goncalves, A., Campone, M., Lardelli, P., Kahatt, C., Nieto, A., Cullell-Young, M., Lubinski, J.

Journal:

Annals of Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 174 KB

english, 2014

17

Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, de Miguel, B, Cullell-Young,

Journal:

British Journal of Cancer

Année:

2013

Langue:

english

Fichier:

PDF, 199 KB

english, 2013

18

Pharmacokinetics, Metabolism, and Routes of Excretion of Intravenous Irofulven in Patients with Advanced Solid Tumors

Paci, A., Rezai, K., Deroussent, A., De Valeriola, D., Re, M., Weill, S., Cvitkovic, E., Kahatt, C., Shah, A., Waters, S., Weems, G., Vassal, G., Lokiec, F.

Journal:

Drug Metabolism and Disposition

Année:

2006

Langue:

english

Fichier:

PDF, 538 KB

english, 2006

19

Acute Myeloid Leukemia Unlikely Related to Trabectedin Treatment

Cartoafa, Mirela, Kahatt, Carmen, Soto-Matos, Arturo, Roy, Elena, Lardelli, Pilar

Journal:

Acta Haematologica

Année:

2011

Langue:

english

Fichier:

PDF, 76 KB

english, 2011

20

Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer

Michaelson, M. D., Bellmunt, J., Hudes, G. R., Goel, S., Lee, R. J., Kantoff, P. W., Stein, C. A., Lardelli, P., Pardos, I., Kahatt, C., Nieto, A., Cullell-Young, M., Lewis, N. L., Smith, M. R.

Journal:

Annals of Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 310 KB

english, 2012

21

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

E. Odore, F. Lokiec, E. Cvitkovic, M. Bekradda, P. Herait, F. Bourdel, C. Kahatt, E. Raffoux, A. Stathis, C. Thieblemont, B. Quesnel, D. Cunningham, M. E. Riveiro, K. Rezaï

Journal:

Clinical Pharmacokinetics

Année:

2016

Langue:

english

Fichier:

PDF, 1.14 MB

english, 2016

22

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

Amorim, Sandy, Stathis, Anastasios, Gleeson, Mary, Iyengar, Sunil, Magarotto, Valeria, Leleu, Xavier, Morschhauser, Franck, Karlin, Lionel, Broussais, Florence, Rezai, Keyvan, Herait, Patrice, Kahatt,

Journal:

The Lancet Haematology

Année:

2016

Langue:

english

Fichier:

PDF, 661 KB

english, 2016

23

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

Berthon, Céline, Raffoux, Emmanuel, Thomas, Xavier, Vey, Norbert, Gomez-Roca, Carlos, Yee, Karen, Taussig, David Christopher, Rezai, Keyvan, Roumier, Christophe, Herait, Patrice, Kahatt, Carmen, Quesn

Journal:

The Lancet Haematology

Année:

2016

Langue:

english

Fichier:

PDF, 483 KB

english, 2016

24

P3.06-002 ATLANTIS Trial: Phase III Study of PM01183/Doxorubicin vs. CAV or Topotecan in SCLC after One Platinum-Containing Line

Farago, Anna, Forster, Martin, Paz-Ares, Luis, Puparelli, Carmen, Szyldergemajn, Sergio, Lopez-Vilarino, Jose, Moss, Keren, Kahatt, Carmen, Soto-Matos, Arturo, Olmedo, Maria Eugenia

Journal:

Journal of Thoracic Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 130 KB

english, 2017

25

Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer

Poveda, A., del Campo, J.M., Ray-Coquard, I., Alexandre, J., Provansal, M., Guerra Alía, E.M., Casado, A., Gonzalez-Martin, A., Fernández, C., Rodriguez, I., Soto, A., Kahatt, C., Fernandez Teruel, C.

Journal:

Annals of Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 1005 KB

english, 2017

26

Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial

Ghouadni, Amal, Delaloge, Suzette, Lardelli, Pilar, Kahatt, Carmen, Byrski, Tomasz, Blum, Joanne L., Gonçalves, Anthony, Campone, Mario, Nieto, Antonio, Alfaro, Vicente, Cullell-Young, Martin, Lubinsk

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 732 KB

english, 2017

27

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma

Ribrag, V., Caballero, D., Ferme, C., Zucca, E., Arranz, R., Briones, J., Gisselbrecht, C., Salles, G., Gianni, A. M., Gomez, H., Kahatt, C., Corrado, C., Szyldergemajn, S., Extremera, S., de Miguel,

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 726 KB

english, 2013

28

Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial

Balmaña, J., Cruz, C., Arun, B.K., Telli, M., Garber, J., Domchek, S., Fernandez, C.M., Kahatt, C., Szyldergemajn, S., Soto-Matos, A., Haza, A. Perez de la, Fidalgo, J.A. Perez, Lluch-Hernandez, A., A

Journal:

Annals of Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 46 KB

english, 2016

29

Antitumor Activity of Lurbinectedin (Pm01183) and Doxorubicin in Relapsed Small Cell Lung Cancer: Results from a Phase I Study

Calvo, E., Moreno, V., Flynn, M., Holgado, E., Olmedo, M.E., Lopez Criado, M.P., Kahatt, C., Lopez-Vilariño, J.A., Siguero, M., Fernandez-Teruel, C., Cullell-Young, M., Soto, A. Matos-Pita, Forster, M

Journal:

Annals of Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 818 KB

english, 2017

30

Lima's PLAM

Kahatt, Sharif S.

Journal:

Journal of Architectural Education

Année:

2016

Langue:

english

Fichier:

PDF, 405 KB

english, 2016

31

MA 01.05 Activity and Safety of the Combination of PM01183 and Doxorubicin in Relapsed SCLC. Final Results of a Phase Ib Trial

Calvo, E., Forster, M., Moreno, V., Olmedo, M.E., Criado, M.P. Lopez, Lopez-Vilariño, J., Kahatt, C., Soto-Matos, A.

Journal:

Journal of Thoracic Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 241 KB

english, 2017

32

P2.04-008 ATLANTIS: Phase III Study of PM01183 with Doxorubicin vs. CAV or Topotecan in Small-Cell Lung Cancer After Platinum Therapy

Farago, A., Paz-Ares, L., Fülop, A., Chiappori, A., Syrigos, K., Lopez-Vilariño, J., Kahatt, C., Kos, G., Soto-Matos, A.

Journal:

Journal of Thoracic Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 361 KB

english, 2017

33

Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC)

Forster, M., Olmedo, M.E., Calvo, E., Moreno, V., Lopez Criado, M.P., Lopez-Vilariño, J.A., Kahatt, C., Lardelli, P., Nuñez, R., Soto-Matos, A.

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 42 KB

english, 2018

34

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis

Soto-Matos, Arturo, Szyldergemajn, Sergio, Extremera, Sonia, Miguel-Lillo, Bernardo, Alfaro, Vicente, Coronado, Cinthya, Lardelli, Pilar, Roy, Elena, Corrado, Claudia Silvia, Kahatt, Carmen

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 329 KB

english, 2011

35

932OPhase III trial of lurbinectedin versus PLD or topotecan in platinum-resistant ovarian cancer patients: Results of CORAIL trial

Gaillard, S, Oaknin, A, Ray-Coquard, I L, Vergote, I B, Scambia, G, Colombo, N, Ghamande, S A, Soto-Matos, A, Fernandez, C M, Kahatt, C, Gomez, J, Nieto, A, Torres, N, Pardo-Burdalo, B, Papai, Z, Kris

Journal:

Annals of Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 93 KB

english, 2018

36

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line

Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, Luis

Journal:

Future Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 2.67 MB

english, 2018

37

P1.12-20 Overall Survival with Lurbinectedin Plus Doxorubicin in Relapsed SCLC. Results from an Expansion Cohort of a Phase Ib Trial

Forster, M., Moreno, V., Calvo, E., Olmedo, M.E., Lopez-Criado, M.P., Lopez-Vilariño, J., Nuñez, R., Kahatt, C., Soto-Matos, A.

Journal:

Journal of Thoracic Oncology

Année:

2018

Fichier:

PDF, 121 KB

2018

38

471PLurbinectedin (LUR) in combination with irinotecan (IRI) in patients (pts) with advanced solid tumours

Aix, S Ponce, Flor, M J, Falcón, A, Simón, I Sánchez, Jimenez, E, Coté, G, Nuñez, R, Siguero, M, Insa, M, Cullell-Young, M, Kahatt, C, Zeaiter, A, Paz-Ares, L

Journal:

Annals of Oncology

Année:

2019

Fichier:

PDF, 83 KB

2019

39

P1.12-03 Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose

Trigo Perez, J.M., Subbiah, V., Besse, B., Moreno, V., López, R., Sala, M.a., Ponce, S., Fernendez, C., Nieto, A., Kahatt, C., Zeaiter, A., Zaman, K., Boni, V., Arrondeau, J., Martinez, M., Delord, J.

Journal:

Journal of Thoracic Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 155 KB

english, 2019

40

P1.12-03 Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose

Trigo Perez, J.M., Subbiah, V., Besse, B., Moreno, V., López, R., Sala, M.a., Ponce, S., Fernendez, C., Nieto, A., Kahatt, C., Zeaiter, A., Zaman, K., Boni, V., Arrondeau, J., Martinez, M., Delord, J.

Journal:

Journal of Thoracic Oncology

Année:

2019

Fichier:

PDF, 155 KB

2019

41

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

Trigo, JosÃ©, Subbiah, Vivek, Besse, Benjamin, Moreno, Victor, LÃ³pez, Rafael, Sala, MarÃa Angeles, Peters, Solange, Ponce, Santiago, FernÃ¡ndez, Cristian, Alfaro, Vicente, GÃ³mez, Javier, Kahatt, Ca

Journal:

The Lancet Oncology

Année:

2020

Langue:

english

Fichier:

PDF, 753 KB

english, 2020

42

Lurbinectedin (PM01183) Activity in Platinum-Resistant/Refractory Ovarian Cancer Patients. Preliminary Results of an Ongoing Two-Stage Phase II Study

Berton-Rigaud, D., Alexandre, J., Provansal, M., Casado, A., Martin, A. Gonzalez, FernÃ¡ndez, C., Kahatt, C., Szyldergemajn, S., Del Campo, J.M., Poveda, A.M., Guerra, E.M., Ray-Coquard, I.

Journal:

Annals of Oncology

Année:

2012

Fichier:

PDF, 59 KB

2012

43

Antitumor Activity of Lurbinectedin in Second-line Small Cell Lung Cancer Patients Who Are Candidates for Re-challenge with the First-line Treatment

Subbiah, Vivek, Paz-Ares, Luis, Besse, Benjamin, Moreno, Victor, Peters, Solange, Sala, MarÃa Angeles, LÃ³pez-VilariÃ±o, JosÃ© Antonio, FernÃ¡ndez, Cristian, Kahatt, Carmen, Alfaro, Vicente, Siguero,

Journal:

Année:

2020

Fichier:

PDF, 2.27 MB

2020

44

1784P Activity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge

Subbiah, V., Paz-Ares, L., Besse, B., Moreno, V., Zaman, K., Sala Gonzalez, M.A., Lopez-Vilarino, J.A., Fernandez, C.M., Kahatt, C., Siguero, M., Zeaiter, A., Lopez Lopez, R., Ponce Aix, S., Boni, V.,

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 116 KB

2020